About PACLIALL (Paclitaxel):
PacliAll is Albumin-bound Paclitaxel. It is used for Ovarian Cancer, Breast cancer, Advanced non-small cell lung cancer. Albumin Bound Paclitaxel is given by a drip into a vein (intravenous infusion), which usually runs over three hours. The infusion is usually repeated every two or three weeks.
What are the common side effects of PACLIALL 100mg?
Nausea, Pain, Diarrhoea, Abdominal pain, Hair loss, Injection site redness, Injection site swelling, Muscle pain, Joint pain, Skin redness, Dry mouth, Sore mouth, Vomiting, Weakness.
Where To buy PACLIALL 100mg (Paclitaxel)?
PACLIALL 100mg (Paclitaxel) is manufactured by Panacea Biotec, India. Legally availabile for public by prescription medicine. To know what is the cost or Maximum Retail Price (MRP) of PACLIALL 100mg (Paclitaxel) in India, please contact +91 8130290915 or email us at email@example.com. IPN will assist you to validate the authenticity of distributor, wholeseller, exporter and suppliers in India for PACLIALL 100mg (Paclitaxel) a prescription drug. Our approved suppliers, wholeseller, exporter and distributor in India will assure you to get genuine medicine against valid documents.
Delivery of PACLIALL 100mg (Paclitaxel)
The Indian Pharma is not an online pharmacy company but we help patient to connect with suppliers in the delivering of PACLIALL 100mg (Paclitaxel) a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed in following countries as per the customer’s prescribed medication and applicable regulatory approval.
Send your inquiry to find PACLIALL (Paclitaxel) in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.